COPD

A risk prediction model may offer insight in evaluating depression and anxiety in patients with chronic obstructive pulmonary disease (COPD).

Results from a study on bronchoscopic lung volume reduction and lung volume reduction surgery may aid medical professionals in selecting the best treatment for patients with emphysema.

Better understanding of risk factors in patients with chronic obstructive pulmonary disease (COPD) and adverse childhood experiences (ACEs) may lead to better management in care.

The researchers said their findings lend support to the idea that urban and transportation planning policies should take into account the needs of patients with chronic disease.

Integrated primary care services may offer better outcomes in patients living with severe chronic obstructive pulmonary disease (COPD) without increasing costs.

The study found that combined therapeutic strategies may help lower the risk.

Continuing the race adjustment factors maintains health care disparities, the authors noted.

Inhaled corticosteroid (ICS) therapy was not the most appropriate treatment for many patients with chronic obstructive pulmonary disease (COPD) in a review of patient records at 2 US primary care clinics.

Patients with diabetes and chronic obstructive pulmonary disease (COPD) have worse outcomes when hospitalized and appear to be more vulnerable to respiratory and nonrespiratory complications after a COPD exacerbation, which highlights the need for targeted interventions in this population.

The authors modeled costs associated with a pedometer-based, web-mediated physical activity intervention compared with a pedometer alone for chronic obstructive pulmonary disease (COPD) management. The intervention was cost-saving.

The results show the importance of diagnosing lung conditions through spirometry as well the necessity for more effective therapies for patients without COPD.

While there are a number of treatment options available for patients with chronic obstructive pulmonary disease, not all options are right for all patients.

While there are a number of treatment options available for patients with chronic obstructive pulmonary disease, not all options are right for all patients.

The researchers noted these improvements were seen without an increase in hyperlactatemia risk.

Beyond smoking, the environment patients live in as well as their occupational risk factors all play large roles in the development of chronic obstructive pulmonary disease (COPD).

Findings from this multicenter randomized controlled trial showed that the transition bundle was associated with a lower risk of 7-day and 30-day hospital readmission from chronic obstructive pulmonary disease (COPD).

From 2001 to 2019 in Europe, overall chronic obstructive pulmonary disease (COPD) prevalence has increased for females and COPD mortality has decreased more so for men than women, according to the results of a recent study.

Smaller lumen sizes in women resulted in worse respiratory morbidity and mortality in chronic obstructive pulmonary disease (COPD), according to a recent study.

Starting noninvasive ventilation at home (NIVH) early after diagnosis was correlated with lower risk of death and reduced Medicare spending for patients with hypercapnic chronic obstructive pulmonary disease with chronic respiratory failure (COPD-CRF), according to a recent study.

US patients with chronic obstructive pulmonary disease (COPD) managed in primary care settings have high exacerbations, symptoms, and treatment burdens, according to an analysis of electronic health record data and patient-reported information/outcomes.

An integrated primary care service may improve the health status of patients with severe chronic obstructive pulmonary disease (COPD) without increasing health care costs, according to a recent study.

A recent study found that teach-to-goal methods are more effective than brief interventions in metered-dose inhaler education for patients with chronic obstructive pulmonary disease (COPD) and asthma, but results may vary depending on levels of health literacy.

Certain characteristics of chronic obstructive pulmonary disease (COPD), including dysphagia risk factors and peak expiratory flow measures, play a role in lowering patients’ voice-related quality of life, according to a recent study.

A cross-sectional, observational study found that triple therapy was initiated in patients with chronic obstructive pulmonary disease (COPD) who experienced poor disease control on maintenance therapy.

A recent study found that pulmonary rehabilitation after hospitalization for chronic obstructive pulmonary disease (COPD) resulted in a net cost savings.